Identity
- Trade Name
- Variolink Esthetic Try In FDA UDI
- Generic Name
- Dental cement trial FDA UDI
- Device Name
- Variolink Esthetic Try. Ref.1.7g light+ FDA UDI
- Model / Reference
- 666067WW FDA UDI
- Description
- Variolink Esthetic Try. Ref.1.7g light+ FDA UDI
Identifiers
- Catalog Number
- 666067WW FDA UDI
- Primary DI / UDI-DI
- DVIV666067WW1 FDA UDI
- FDA Product Code
- EBF FDA UDI
- GMDN Term
- Dental cement trial FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 872.3690 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
Yes
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
Yes
FDA UDI
Category: Dental cement trial
Variolink Esthetic Try In by Ivoclar Vivadent Aktiengesellschaft — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Dental cement trial.
- Choice 2 Try-In Paste — BISCO INC. · Class II
- eCement Try-In Paste — BISCO INC. · Class I
- Mojo — KERR CORPORATION · Class II
- Choice 2 Try-In Paste — BISCO INC. · Class II
- G-CEM LinkForce™ — Gc America Inc. · Class II
- eCement Try-In Paste — BISCO INC. · Class I
- Choice 2 Try-In Paste — BISCO INC. · Class II
- Mojo — KERR CORPORATION · Class II
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Ivoclar Vivadent Aktiengesellschaft
Sources (1)
- FDA UDI 8f3a8c68-fbb5-4222-9af0-02e87c70b734 34 fields · synced Jun 8, 2026